Clinical Trials · NCT01677104

The Microvascular Function of GLP-1 and Its Analogues

CompletedN/ALiraglutide (Approved)Exenatide (Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
Katarina Kos
Enrollment
63
Start date
Aug 2012
Locations
1 site, United Kingdom
Primary endpoint
skin blood flow
View Liraglutide compound reference